Copyright
©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1808-1814
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1808
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1808
Table 6 Telomerase assay of PS-ODN treated P3 cells (-x±s)
| PS-ODN | C0(0) B(-x±s) | C1(3.16) B(-x±s) | C2(10) B(-x±s) | C3(31.6) B(-x±s) | C4(100) B(-x±s) |
| PS-ODN1 | 2.25 ± 0.56 | 1.53 ± 0.23 | 1.20 ± 0.15 | 0.97 ± 0.12 | 0.65 ± 0.47 |
| PS-ODN2 | 2.25 ± 0.56 | 1.66 ± 0.46 | 1.40 ± 0.44 | 0.69 ± 0.29 | 0.49 ± 0.32 |
| PS-ODN3 | 2.25 ± 0.56 | 2.28 ± 0.32 | 2.32 ± 0.37 | 2.26 ± 0.31 | 2.19 ± 0.26 |
| PS-ODN4 | 2.25 ± 0.56 | 2.16 ± 0.35 | 2.24 ± 0.50 | 2.27 ± 0.43 | 2.13 ± 0.38 |
- Citation: Zhou JH, Zhang HM, Chen Q, Han DD, Pei F, Zhang LS, Yang DT. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma. World J Gastroenterol 2003; 9(8): 1808-1814
- URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1808.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1808